The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
Index/Leadership/The Jess Larsen Show on Innovation & Leadership
The Jess Larsen Show on Innovation & Leadership artwork

Raising $200M & Building AI for Drug Discovery | BenchSci Co-founder and CEO, Liran Belenzon

The Jess Larsen Show on Innovation & Leadership · 2026-05-28 · 44 min

0:00--:--

Episode notes

Most people don’t realize how broken drug discovery really is. According to Liran Belenzon, companies can spend seven years and hundreds of millions of dollars on a drug candidate - only to see it fail in human trials. In this episode, Liran explains why biology is one of the most complex systems humans have ever tried to understand and how AI can help researchers uncover patterns humans miss. The discussion explores why even small improvements in success rates could completely reshape healthcare outcomes worldwide. This episode is a powerful glimpse into the future of science and medicine. Learn more about your ad choices. Visit megaphone.fm/adchoices

More from The Jess Larsen Show on Innovation & Leadership

All episodes →
  • How Did He Grow to 2 Million Customers? | KOHO Co-Founder and CEO, Daniel Eberhard79 / 100
  • Why do 75% of Exits Fail? | Michael Winn, Co-Founder & Partner at Chartered Wealth Partners
  • Ethereum Co-Founder's Sovereign AI Future | Anthony Di Iorio, CEO & Founder of Decentral
  • $2.5B in Real Estate to Fulfillionaire | Thrive CEO JP Newman
  • Why the Rich are Moving to the Cayman Islands? | Daniel Altneu & Co-hosted with Holly Parker
Explore the best B2B Leadership podcasts →
All The Jess Larsen Show on Innovation & Leadership episodes →